Literature DB >> 30639873

Osteopontin potentiates PM-induced IL-1α and IL-1β production via the ERK/JNK signaling pathway.

Jian Wang1, Jianan Huang1, Mengchan Zhu1, Shujing Chen1, Cuicui Chen1, Changhong Miao2, Hong He3, Yuanlin Song4.   

Abstract

Ambient particulate matter (PM) poses a great threat to global health and contributes to pulmonary inflammation. However, the potential mechanism of PM-induced inflammation of the lung remains unclear. Osteopontin (OPN) is a multifunctional protein that reportedly regulates inflammatory responses in different diseases. Here, we explored the expression of OPN with PM exposure in vivo and in vitro and attempted to elucidate the regulatory role of OPN in PM-induced airway inflammation. Our results showed that PM exposure increased the expression of OPN in the bronchial epithelium, serum, and bronchoalveolar lavage fluid (BALF) of mice. Moreover, PM induced OPN expression in human bronchial epithelial cells (HBECs) in a dose and time-dependent manner. In vitro, inflammatory cytokines such as IL-1α and IL-1β were increased in HBECs with PM exposure via the ERK and JNK signaling pathways. Recombinant human OPN could potentiate PM-induced expression of IL-1α and IL-1β, while OPN siRNA could alleviate PM-induced inflammatory responses in HBECs. Furthermore, we showed that OPN regulated PM-induced inflammatory cytokines via the ERK and JNK pathways in HBECs. This study shows for the first time the positive effect of OPN on PM-induced airway inflammation and contributes to a better understanding of its potential mechanism of action.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Inflammation; Osteopontin; Particulate matter; Signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 30639873     DOI: 10.1016/j.ecoenv.2019.01.005

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  7 in total

Review 1.  Aerobic Physical Exercise as a Non-medical Intervention for Brain Dysfunction: State of the Art and Beyond.

Authors:  Yuxiang Jia; Yu Yao; Limin Zhuo; Xingxing Chen; Cuina Yan; Yonghua Ji; Jie Tao; Yudan Zhu
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

2.  Edaravone Attenuated Particulate Matter-Induced Lung Inflammation by Inhibiting ROS-NF-κB Signaling Pathway.

Authors:  Yingying Zeng; Guiping Zhu; Mengchan Zhu; Juan Song; Hui Cai; Yuanlin Song; Jian Wang; Meiling Jin
Journal:  Oxid Med Cell Longev       Date:  2022-04-23       Impact factor: 7.310

Review 3.  The Yin-Yang of osteopontin in nervous system diseases: damage versus repair.

Authors:  Giuseppe Cappellano; Domizia Vecchio; Luca Magistrelli; Nausicaa Clemente; Davide Raineri; Camilla Barbero Mazzucca; Eleonora Virgilio; Umberto Dianzani; Annalisa Chiocchetti; Cristoforo Comi
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

4.  White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains.

Authors:  Gisela Nilsson; Ana A Baburamani; Mary A Rutherford; Changlian Zhu; Carina Mallard; Henrik Hagberg; Regina Vontell; Xiaoyang Wang
Journal:  Acta Neuropathol Commun       Date:  2021-10-15       Impact factor: 7.801

Review 5.  Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders.

Authors:  Hongzhen Chen; Dewei Shang; Yuguan Wen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-06-10

6.  MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway.

Authors:  Jian Wang; Mengchan Zhu; Ling Ye; Cuicui Chen; Jun She; Yuanlin Song
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

Review 7.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.